| Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors. | |
| | |
MedLine Citation:
|
PMID: 15158142 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: An increased expression of adenosine receptors is a promising target for gene therapy aimed at protecting the myocardium against ischemic damage, but may alter cardiac electrophysiology. We therefore studied the effects of heart-directed overexpression of A(3) adenosine receptors (A(3)ARs) at different gene doses on sinus and atrio-ventricular (AV) nodal function in mice. METHODS AND RESULTS: Mice with heart-specific overexpression of A(3)AR at high (A(3)(high)) or low (A(3)(low)) levels and their wild-type littermates were studied. Telemetric electrocardiogram (ECG) recordings in adult freely moving A(3)(high) mice showed profound sinus bradycardia resulting in either ventricular escape rhythms or an incessant bradycardia-tachycardia syndrome (minimal heart rate A(3)(high) 217+/-25*; WT 406+/-21 beats/min, all values as mean+/-S.E.M., n=7 per genotype, *p<0.05). Exercise attenuated bradycardia in A(3)(high) mice (maximal heart rate A(3)(high) 650+/-13*; WT 796+/-13 beats/min) and first-degree AV nodal block was present (PQ interval A(3)(high) 36+/-4*; WT 23+/-5 ms). Isolated hearts showed complete heart block (10/17 A(3)(high)* vs. 1/17 WT). Atrial bradycardia and AV block were already present 3 weeks after birth. Doppler echocardiography revealed atrial dysfunction and progressive atrial enlargement that was moderate at 3 and 8 weeks, and progressed at 12 and 21 weeks of age (all p<0.05 vs. WT). Atrial contractility and sarcoendoplasmic Ca(2+) ATPase (SERCA) 2a protein expression were reduced in isolated left A(3)(high) atria at the age of 14 weeks. Fibrosis was present in left A(3)(high) atria at 14 weeks, but not at 5 weeks of age. A(3)(low) mice had first-degree AV block without arrhythmias or structural changes. CONCLUSIONS: Heart-directed overexpression of A(3)AR resulted in gene dose-dependent AV block and pronounced sinus nodal dysfunction in vivo. Profound bradycardia heralded atrial and ventricular dilatation, dysfunction, and fibrosis. In contrast to A(1) adenosine receptors (A(1)AR), the effects of A(3)AR overexpression were attenuated during exercise. This may have implications for the physiology of sinus nodal regulation and for therapeutic attempts to increase the expression of adenosine receptors. |
| | |
Authors:
|
Larissa Fabritz; Paulus Kirchhof; Lisa Fortmüller; John A Auchampach; Hideo A Baba; Günter Breithardt; Joachim Neumann; Peter Boknik; Wilhelm Schmitz |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Cardiovascular research Volume: 62 ISSN: 0008-6363 ISO Abbreviation: Cardiovasc. Res. Publication Date: 2004 Jun |
Date Detail:
|
Created Date: 2004-05-25 Completed Date: 2004-10-04 Revised Date: 2011-10-04 |
Medline Journal Info:
|
Nlm Unique ID: 0077427 Medline TA: Cardiovasc Res Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 500-8 Citation Subset: IM |
Affiliation:
|
Department of Cardiology and Angiology and Institute for Arteriosclerosis Research, University Hospital Münster, Muenster, Germany. fabritzl@uni-muenster.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Arrhythmias, Cardiac / genetics*, physiopathology Atrioventricular Node / physiopathology Cardiomyopathy, Dilated / genetics*, physiopathology Echocardiography, Doppler Electrocardiography Gene Expression Heart Block / genetics, physiopathology Mice Mice, Transgenic Perfusion Receptor, Adenosine A3 / genetics* Sinoatrial Node / physiopathology |
| Grant Support | |
ID/Acronym/Agency:
|
R01 HL060051-04/HL/NHLBI NIH HHS; R01 HL060051-05/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Receptor, Adenosine A3 |
| Comments/Corrections | |
Comment In:
|
Cardiovasc Res. 2004 Jun 1;62(3):447-9
[PMID:
15158136
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The transcriptional repressor Tbx3 delineates the developing central conduction system of the heart.
Next Document: The phosphoinositide 3-kinase inhibitor LY294002 enhances cardiac myocyte contractility via a direct...